这是一篇来自已证抗体库的有关人类 EphA4的综述,是根据15篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合EphA4 抗体。
EphA4 同义词: EK8; HEK8; SEK; TYRO1

赛默飞世尔
小鼠 单克隆(4C8H5)
  • 免疫印迹; 小鼠; 1:250; 图 10a
赛默飞世尔 EphA4抗体(Invitrogen, 37-1600)被用于被用于免疫印迹在小鼠样本上浓度为1:250 (图 10a). J Neurosci (2022) ncbi
小鼠 单克隆(4C8H5)
  • 免疫印迹; 人类; 图 7d
赛默飞世尔 EphA4抗体(ThermoFisher, 4C8H5)被用于被用于免疫印迹在人类样本上 (图 7d). J Virol (2018) ncbi
小鼠 单克隆(4C8H5)
  • 免疫印迹; 小鼠; 1:1000; 图 3a
赛默飞世尔 EphA4抗体(Invitrogen, 37-1600)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3a). Development (2017) ncbi
小鼠 单克隆(4C8H5)
  • 免疫沉淀; 人类; 图 4a
  • 免疫印迹; 人类; 图 4a
赛默飞世尔 EphA4抗体(生活技术, 37-1600)被用于被用于免疫沉淀在人类样本上 (图 4a) 和 被用于免疫印迹在人类样本上 (图 4a). Exp Cell Res (2016) ncbi
小鼠 单克隆(4C8H5)
  • 免疫印迹; 小鼠; 1:200
赛默飞世尔 EphA4抗体(Invitrogen, 37-1600)被用于被用于免疫印迹在小鼠样本上浓度为1:200. Eur J Neurosci (2014) ncbi
小鼠 单克隆(4C8H5)
  • 免疫印迹; 小鼠; 1:200; 图 3
赛默飞世尔 EphA4抗体(Invitrogen, 37-1600)被用于被用于免疫印迹在小鼠样本上浓度为1:200 (图 3). Eur J Neurosci (2013) ncbi
小鼠 单克隆(4C8H5)
  • 免疫印迹; 小鼠; 1:1000; 图 s2
赛默飞世尔 EphA4抗体(Zymed, 37-1600)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s2). Hum Mol Genet (2013) ncbi
小鼠 单克隆(4C8H5)
  • 免疫组化; 小鼠
赛默飞世尔 EphA4抗体(Invitrogen, 37-1600)被用于被用于免疫组化在小鼠样本上. Mol Cell Biol (2013) ncbi
小鼠 单克隆(4C8H5)
  • 免疫印迹; 小鼠; 1:1000; 图 4
赛默飞世尔 EphA4抗体(Zymed, 37-1600)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4). Nat Med (2012) ncbi
小鼠 单克隆(4C8H5)
  • 免疫沉淀; 小鼠; 图 5
赛默飞世尔 EphA4抗体(Zymed, 4C8H5)被用于被用于免疫沉淀在小鼠样本上 (图 5). PLoS ONE (2008) ncbi
小鼠 单克隆(4C8H5)
  • 免疫印迹; 小鼠; 图 1
赛默飞世尔 EphA4抗体(Zymed, 4C8H5)被用于被用于免疫印迹在小鼠样本上 (图 1). Neuron (2007) ncbi
艾博抗(上海)贸易有限公司
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:500; 图 8c
艾博抗(上海)贸易有限公司 EphA4抗体(Abcam, ab62256)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 8c). Oncogene (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 3b
艾博抗(上海)贸易有限公司 EphA4抗体(Abcam, ab193214)被用于被用于免疫印迹在人类样本上 (图 3b). Breast Cancer Res (2019) ncbi
圣克鲁斯生物技术
小鼠 单克隆(35)
  • 免疫印迹; 大鼠
圣克鲁斯生物技术 EphA4抗体(Santa Cruz Biotechnology, sc-135897)被用于被用于免疫印迹在大鼠样本上. PLoS ONE (2014) ncbi
碧迪BD
小鼠 单克隆(35/EphA4)
  • 免疫组化-石蜡切片; 小鼠; 1:100
碧迪BD EphA4抗体(BD Biosciences, 610471)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100. Development (2013) ncbi
文章列表
  1. Matsuura K, Kobayashi S, Konno K, Yamasaki M, Horiuchi T, Senda T, et al. SIPA1L1/SPAR1 Interacts with the Neurabin Family of Proteins and is Involved in GPCR Signaling. J Neurosci. 2022;42:2448-2473 pubmed 出版商
  2. Ricci B, Millner T, Pomella N, Zhang X, Guglielmi L, Badodi S, et al. Polycomb-mediated repression of EphrinA5 promotes growth and invasion of glioblastoma. Oncogene. 2020;39:2523-2538 pubmed 出版商
  3. Hori A, Shimoda M, Naoi Y, Kagara N, Tanei T, Miyake T, et al. Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer. Breast Cancer Res. 2019;21:88 pubmed 出版商
  4. TerBush A, Hafkamp F, Lee H, Coscoy L. A Kaposi's Sarcoma-Associated Herpesvirus Infection Mechanism Is Independent of Integrins α3β1, αVβ3, and αVβ5. J Virol. 2018;92: pubmed 出版商
  5. Rothe M, Kanwal N, Dietmann P, Seigfried F, Hempel A, Schütz D, et al. An Epha4/Sipa1l3/Wnt pathway regulates eye development and lens maturation. Development. 2017;144:321-333 pubmed 出版商
  6. Jurek A, Genander M, Kundu P, Catchpole T, He X, Strååt K, et al. Eph receptor interclass cooperation is required for the regulation of cell proliferation. Exp Cell Res. 2016;348:10-22 pubmed 出版商
  7. Joly S, Jordi N, Schwab M, Pernet V. The Ephrin receptor EphA4 restricts axonal sprouting and enhances branching in the injured mouse optic nerve. Eur J Neurosci. 2014;40:3021-31 pubmed 出版商
  8. Vargas L, Leal N, Estrada L, González A, Serrano F, Araya K, et al. EphA4 activation of c-Abl mediates synaptic loss and LTP blockade caused by amyloid-β oligomers. PLoS ONE. 2014;9:e92309 pubmed 出版商
  9. Kempf A, Montani L, Petrinovic M, Schroeter A, Weinmann O, Patrignani A, et al. Upregulation of axon guidance molecules in the adult central nervous system of Nogo-A knockout mice restricts neuronal growth and regeneration. Eur J Neurosci. 2013;38:3567-79 pubmed 出版商
  10. Yang Z, Zimmerman S, BRAKEMAN P, Beaudoin G, Reichardt L, MARCIANO D. De novo lumen formation and elongation in the developing nephron: a central role for afadin in apical polarity. Development. 2013;140:1774-84 pubmed 出版商
  11. Lemmens R, Jaspers T, Robberecht W, Thijs V. Modifying expression of EphA4 and its downstream targets improves functional recovery after stroke. Hum Mol Genet. 2013;22:2214-20 pubmed 出版商
  12. Semerdjieva S, Abdul Razak H, Salim S, Yáñez Muñoz R, Chen P, Tarabykin V, et al. Activation of EphA receptors mediates the recruitment of the adaptor protein Slap, contributing to the downregulation of N-methyl-D-aspartate receptors. Mol Cell Biol. 2013;33:1442-55 pubmed 出版商
  13. Van Hoecke A, Schoonaert L, Lemmens R, Timmers M, Staats K, Laird A, et al. EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nat Med. 2012;18:1418-22 pubmed
  14. Yumoto N, Wakatsuki S, Kurisaki T, Hara Y, Osumi N, Frisen J, et al. Meltrin beta/ADAM19 interacting with EphA4 in developing neural cells participates in formation of the neuromuscular junction. PLoS ONE. 2008;3:e3322 pubmed 出版商
  15. Beg A, Sommer J, Martin J, Scheiffele P. alpha2-Chimaerin is an essential EphA4 effector in the assembly of neuronal locomotor circuits. Neuron. 2007;55:768-78 pubmed